Leap Therapeutics Quote - LPTX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.5599

Bid

0.5573

Ask

0.5599

Volume

3,357,670

0.55 Day's Range 0.66

0.555 52 Week Range 4.79

Market Cap

21.454M

Previous Close

0.65

Open

0.66

Last Trade

0.5593

Last Trade Time

15:46:40

Financial Volume

US$ 1,931,369

VWAP

0.575211

Average Volume (3m)

634,874

Shares Outstanding

38,317,897

Dividend Yield

PE Ratio

-0.27

Earnings Per Share (EPS)

-2.12

Revenue

Net Profit

-81.41M

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib... Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.leaptx.com

Headquarters

Wilmington, Delaware, USA

Founded

Leap Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LPTX. The last closing price for Leap Therapeutics was US$0.65. Over the last year, Leap Therapeutics shares have traded in a share price range of US$ 0.555 to US$ 4.79.

Leap Therapeutics currently has 38,317,897 shares outstanding. The market capitalization of Leap Therapeutics is US$24.91 million. Leap Therapeutics has a price to earnings ratio (PE ratio) of -0.27.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.8801	-77.0532786885	2.44	2.45	0.555	3823581	0.92100038	CS
4	-2.3401	-80.6931034483	2.9	3.58	0.555	1302030	1.44642796	CS
12	-3.0001	-84.2724719101	3.56	3.92	0.555	634874	2.06561134	CS
26	-1.6401	-74.55	2.2	4.79	0.555	397114	2.38524391	CS
52	-1.8501	-76.7676348548	2.41	4.79	0.555	319233	2.54401033	CS
156	-16.7401	-96.763583815	17.3	25.7	0.555	525821	7.84116266	CS
260	-16.9401	-96.8005714286	17.5	41.7	0.555	912467	19.03730604	CS

LPTX - Frequently Asked Questions (FAQ)

What is the current Leap Therapeutics share price?

The current share price of Leap Therapeutics is US$ 0.5599

How many Leap Therapeutics shares are in issue?

Leap Therapeutics has 38,317,897 shares in issue

What is the market cap of Leap Therapeutics?

The market capitalisation of Leap Therapeutics is USD 24.91M

What is the 1 year trading range for Leap Therapeutics share price?

Leap Therapeutics has traded in the range of US$ 0.555 to US$ 4.79 during the past year

What is the PE ratio of Leap Therapeutics?

The price to earnings ratio of Leap Therapeutics is -0.27

What is the reporting currency for Leap Therapeutics?

Leap Therapeutics reports financial results in USD

What is the latest annual profit for Leap Therapeutics?

The latest annual profit of Leap Therapeutics is USD -81.41M

What is the registered address of Leap Therapeutics?

The registered address for Leap Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Leap Therapeutics website address?

The website address for Leap Therapeutics is www.leaptx.com

Which industry sector does Leap Therapeutics operate in?

Leap Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OSTOstin Technology Group Company Ltd	US$ 3.89 (32.76%)	1.34M
PCSAProcessa Pharmaceuticals Inc	US$ 0.7781 (31.37%)	1.47M
CARMCarisma Therapeutics Inc	US$ 0.61 (20.86%)	3.93M
ASSTAsset Entities Inc	US$ 0.9499 (15.14%)	156.95k
IVAInventiva SA	US$ 2.62 (13.91%)	19.87k
CRGXCARGO Therapeutics Inc	US$ 3.84 (-70.89%)	699.8k
FIBKFirst Interstate BancSystem Inc	US$ 27.25 (-17.07%)	8.49k
DGNXDiginex Ltd	US$ 42.2417 (-15.77%)	118.98k
MXLMaxLinear Inc	US$ 18.59 (-14.69%)	74.4k
IKTInhibikase Therapeutics Inc	US$ 2.39 (-14.64%)	232.77k
NVDANVIDIA Corporation	US$ 125.77 (1.67%)	28.71M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 26.43 (6.87%)	14.41M
TSLATesla Inc	US$ 402.5392 (3.45%)	10.25M
VCSHVanguard Short Term Corporate Bond	US$ 78.41 (0.00%)	9.57M
MGOLMGO Global Inc	US$ 0.1143 (12.39%)	6.04M